These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2472897)

  • 1. Is thiacetazone necessary or useful in the intensive phase of anti-tuberculous chemotherapy?
    McLeod DT; Pringle D; Zingoni T; Mbengeranwa OL
    Cent Afr J Med; 1989 Jan; 35(1):313-6. PubMed ID: 2472897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koulla-Shiro S
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
    Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of multidrug-resistant pulmonary tuberculosis cured by the regimen including thiacetazone].
    Wada M; Mizutani S; Nakajima Y; Ito K; Mitarai S; Hoshino H; Okumura M; Yoshiyama T; Ogata H
    Kekkaku; 2007 Jan; 82(1):33-7. PubMed ID: 17310780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-threatening cutaneous reactions to thiacetazone-containing antituberculosis treatment in Kumasi, Ghana.
    Lawn SD; Frimpong EH; Acheampong JW
    West Afr J Med; 1999; 18(4):249-53. PubMed ID: 10734785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two short course tuberculosis chemotherapy regimens, both using Rifater during an intensive phase, with a 3 year follow-up.
    Punnotok J; Pumprueg U; Chakorn T
    J Med Assoc Thai; 1995 Jun; 78(6):298-304. PubMed ID: 7561554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of fixed drug eruptions and Stevens Johnson syndrome due to thiacetazone in a patient of pulmonary tuberculosis.
    Gupta PK; Luniya AK; Gupta NK; Tiwari ML
    Indian J Chest Dis Allied Sci; 1983; 25(2):152-4. PubMed ID: 6197367
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent chemotherapy with thiacetazone and isoniazid in the treatment of pulmonary tuberculosis.
    Krishnaswami KV
    Indian J Chest Dis Allied Sci; 1977 Oct; 19(4):177-87. PubMed ID: 77844
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents].
    Gergert VIa; Rusakova LI
    Probl Tuberk Bolezn Legk; 2006; (8):33-7. PubMed ID: 17002056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome due to thiacetazone.
    Hussain SA; Saksena HC; Kothari RP
    J Indian Med Assoc; 1973 Jan; 60(2):57-9. PubMed ID: 4123241
    [No Abstract]   [Full Text] [Related]  

  • 14. Thiacetazone toxicity in the treatment of tuberculosis patients in Nigeria.
    Pearson CA
    J Trop Med Hyg; 1978 Dec; 81(12):238-42. PubMed ID: 85717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled therapeutic study of 5 intermittent chemotherapy regimens for pulmonary tuberculosis. 4th international study of the UICT].
    Bignall JR
    Bull Int Union Tuberc; 1974; 49(1):422-6. PubMed ID: 4143179
    [No Abstract]   [Full Text] [Related]  

  • 16. [Skin toxicity of thiacetazone (TB1) at a hospital service in Dakar].
    Dieng MT; Ndiaye B; Camara C
    Dakar Med; 2001; 46(1):1-3. PubMed ID: 15773145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lyell syndrome in Senegal: responsibility of thiacetazone].
    Mame Thierno D; On S; Thierno Ndiaye S; Ndiaye B
    Ann Dermatol Venereol; 2001 Dec; 128(12):1305-7. PubMed ID: 11908132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous reactions to thiacetazone (TB1) (author's transl)].
    Strobel M; Ndiaye B; Marchand JP; Jovet JC
    Rev Fr Mal Respir; 1979; 7(5):467-70. PubMed ID: 95055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survey of the initial treatment of pulmonary tuberculosis in West Germany. A study by the German Central Committee for the Prevention of Tuberculosis].
    Zierski M; Hoffmann O; Bornhardt E
    Pneumologie; 1989 Dec; 43(12):691-702. PubMed ID: 2622876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.